About the SELECT Trial 7 SELECT was a randomized, double-blind, parallel-group, placebo-controlled trial designed to evaluate the efficacy of semaglutide 2.4 mg versus placebo as an adjunct to standard of care for prevention of major adverse cardiovascular outcomes (MACE) in people with established cardiovascular disease with overweight or obesity with no prior history of diabetes
It avoids androgenic side effects common with anabolic steroids
Liposuction After GLP-1 Weight Loss January 6, 2025 John Bergeron MD Medically reviewed by John Bergeron, MD Medical weight loss programs that include prescription appetite suppressants such as Semaglutide and Tirzepatide are highly effective for helping patients lose significant amounts of weight and improving overall health outcomes
Acta imitando la hormona GLP-1, que acta en el cerebro para reducir el apetito y aumentar la sensacin de saciedad, favoreciendo as la prdida de peso
Consequently, AOD9604 5mg should be regarded as an investigational research compound intended exclusively to support laboratory research and scientific discovery
Such as heart attack and stroke, in the age group of people with type 2 diabetes